Kinesin 'chauffeur' helps HIV escape destruction

October 22, 2012
A JCB study identifies a motor protein that ferries HIV to the plasma membrane along microtubules, helping the virus escape from macrophages. In these images of a macrophage, the distribution of virus-containing compartments (green) where HIV assembles changes after microtubules (red) are disrupted (right). Credit: Gaudin, R., et al., 2012. J. Cell Biol. doi:10.1083/jcb.201201144

A study in The Journal of Cell Biology identifies a motor protein that ferries HIV to the plasma membrane, helping the virus escape from macrophages.

HIV reproduces inside disease-fighting T cells, killing them in the process. But the virus can also replicate in macrophages, which survive infection and serve as reservoirs of HIV. In T cells, new are formed at the plasma membrane, but in macrophages the viruses assemble inside cytoplasmic containers called virus-containing compartments (VCCs). To break out of a macrophage, a virus particle therefore has to travel to the .

A group of researchers led by Philippe Benaroch (INSERM, Paris) showed that the virus hitches a ride with the microtubule-based kinesin motor protein KIF3A. The researchers found that reducing the level of KIF3A dramatically reduced the release of HIV particles from macrophages. Yet the procedure did not have any effect on the amount of HIV escaping from T cells. KIF3A drives HIV along microtubules, the researchers discovered; they observed KIF3A proteins and VCCs moving in tandem along the microtubule filaments. Consistent with this, VCCs build up in cells lacking KIF3A, suggesting that their movements stall in the absence of the kinesin. How HIV exits VCCs remains uncertain, but the results indicate that inhibiting KIF3A might offer a new way to combat the virus.

More information: Gaudin, R., et al., 2012. J. Cell Biol. doi:10.1083/jcb.201201144

Related Stories

Recommended for you

HVTN 505 vaccine induced antibodies nonspecific for HIV

July 30, 2015

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...

Vitamin D status related to immune response to HIV-1

June 15, 2015

Vitamin D plays an important part in the human immune response and deficiency can leave individuals less able to fight infections like HIV-1. Now an international team of researchers has found that high-dose vitamin D supplementation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.